Previous 10 | Next 10 |
HAUPPAUGE, N.Y., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) a leading point-of-care diagnostic company focused on infectious diseases, today announced it has been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA),...
FinancialBuzz.com News Commentary New York, NY (11/19/2020) – Recent reports from across the country clearly show that infection cases are once again surging. More than 11.4 million Americans have now been infected with the virus and the number of deaths has surpassed 248,000. In...
The FDA has issued an emergency use authorization ((EUA)) to the single-use COVID-19 diagnostic test kit from Lucira Health, a California manufacturer.The Lucira COVID-19 All-In-One at home test kit provides rapid results. To date, the Agency has authorized nearly 300 test...
5 Penny Stocks On Robinhood To Watch This Week Are you looking for penny stocks to buy ? You’re not alone and the last few weeks have been big for small cap stocks . When the market goes into a funk as it did around election time, it can be hard to find your rhythm. That&...
HAUPPAUGE, N.Y., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that its subsidiary Chembio Diagnostics Brazil Ltda. has received regulatory approval from Agênci...
The sellers of diagnostic tests for SARS-CoV-2 and antibodies to the coronavirus are under early pressure in apparent reaction to positive interim data on Pfizer and BioNTech's COVID-19 vaccine that showed 90% efficacy. An effective vaccine, when widely deployed, will imply reduced testing de...
Chembio Diagnostics, Inc. (CEMI) Q3 2020 Results Conference Call November 05, 2020 04:30 PM ET Company Participants Philip Taylor - IR Rick Eberly - President and CEO Neil Goldman - EVP and CFO Conference Call Participants Kyle Bauser - Collier Securities Presentation Operator Good day, ladie...
FTS International (FTSI) +67% after successful confirmation of plan of reorganization.Mogo (MOGO) +58% after announcing MogoSpend supports Apple Pay, Google Pay and Samsung Pay.GoPro (GPRO) +21% on Q3 results.Glu Mobile (GLUU) +17% on Q3 results.Aurora ...
HAUPPAUGE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended September 30, 2020. Recent Accomplishments & Highlights...
HAUPPAUGE, N.Y., Oct. 23, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter 2020 after the close of trading on Thursday, ...
News, Short Squeeze, Breakout and More Instantly...
Chembio Diagnostics Inc. Company Name:
CEMI Stock Symbol:
NASDAQ Market:
Chembio Diagnostics Inc. Website:
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...
MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 ...